AbbVie Inc. (ABBV) vs Amgen Inc. (AMGN)
AMGN leads on 8 of 13 compared metrics.
A side-by-side comparison of AbbVie Inc. and Amgen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — ABBV vs AMGN
growth of $100 · last 14yABBV +550.7%AMGN +295.8%ABBV compounded faster
ABBV AMGN
ABBV vs AMGN: by the numbers
- •ABBV is the larger company ($402.35B vs $191.70B market cap).
- •AMGN trades at the lower earnings multiple (24.72 vs 111.67 P/E).
- •AMGN converts more revenue to profit (20.95% vs 5.79% net margin).
- •AMGN grew revenue faster over the past five years (8.15% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.96% vs 2.76%).
Which is better, ABBV or AMGN?
Metric tally: ABBV 5 · AMGN 8It depends on what you're optimizing for:
ValueAMGN(lower P/E)
GrowthAMGN(faster 5Y revenue CAGR)
IncomeABBV(higher dividend yield)
Valuation
| Metric | ABBV | AMGN |
|---|---|---|
| P/E ratio | 111.67 | 24.72● |
| Forward P/E | — | 15.15 |
| P/S ratio | 6.43 | 5.19● |
| P/B ratio | 14.69● | 21.03 |
| PEG ratio | — | 0.26 |
| EV / EBITDA | 27.63 | 14.29● |
| FCF yield | 5.17%● | 4.45% |
Profitability
| Metric | ABBV | AMGN |
|---|---|---|
| Gross margin | 70.68% | 71.46% |
| Operating margin | 27.60% | 31.63%● |
| Net margin | 5.79% | 20.95%● |
| ROE | 13.23% | 84.87%● |
| ROIC | 12.97% | 13.16% |
Dividends
| Metric | ABBV | AMGN |
|---|---|---|
| Dividend yield | 2.96%● | 2.76% |
| Payout ratio | 284.39% | 68.39% |
Growth (annualized)
| Metric | ABBV | AMGN |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 8.15%● |
| EPS CAGR (5Y) | -2.79% | 2.94%● |
| FCF CAGR (5Y) | 3.24%● | -2.66% |
| Total return CAGR (5Y) | 18.95%● | 11.36% |
Frequently asked
- Which is better, ABBV or AMGN?
- It depends on your goal. value: AMGN (lower P/E); growth: AMGN (faster 5Y revenue CAGR); income: ABBV (higher dividend yield). Across all compared metrics, AMGN leads 8 to 5.
- Is ABBV or AMGN cheaper?
- On trailing earnings, AMGN is cheaper: ABBV trades at a 111.67 P/E and AMGN at 24.72.
- Which has grown faster, ABBV or AMGN?
- Over the past five years, AMGN grew revenue faster — ABBV at a 4.59% CAGR versus AMGN at 8.15%.
- Does ABBV or AMGN pay a bigger dividend?
- ABBV yields 2.96% and AMGN yields 2.76% based on trailing dividends and the latest price.
- Is ABBV or AMGN more profitable?
- AMGN runs the higher net margin — ABBV at 5.79% versus AMGN at 20.95%.
- Which has been the better investment, ABBV or AMGN?
- Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus AMGN at 11.94%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioAmgen P/E ratioAbbVie dividend yieldAmgen dividend yieldAbbVie ROEAmgen ROEAbbVie operating marginAmgen operating marginAbbVie revenue growthAmgen revenue growthAbbVie free cash flowAmgen free cash flow
AbbVie & Amgen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.